Le Lézard
Classified in: Health, Science and technology
Subject: Recall

KRS Global Biotechnology, Inc. Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products Due to Lack of Assurance of Sterility


KRS Global Biotechnology, Inc. is voluntarily recalling all lots of unexpired human and animal drugs intended to be sterile to the consumer level. The products are being recalled due to lack of assurance of sterility.

Administration of a drug product intended to be sterile that is not sterile could result in serious infections which may be life-threatening. To date, KRS Global Biotechnology, Inc. has not received any reports of adverse events related to this recall.

The affected products are listed below and include a lot number and expiration date. The products can be identified by a KRS Global Biotechnology, Inc. label. Products were distributed nationwide to hospitals, doctor's offices, surgical centers, pharmacies, veterinarians and patients.

KRS Global Biotechnology, Inc. is notifying its customers by mail, telephone, or email and is arranging for credit of all recalled products.

Health Care Providers that have these products which are being recalled should stop using them and return to KRS Global Biotechnology, Inc.

Consumers that have these products which are being recalled should stop using them and contact their doctor or health care provider.

Consumers with questions regarding this recall can contact KRS Global Biotechnology, Inc. by phone 888-398-9950 or [email protected]. We are available Monday through Friday from 9 AM to 5 PM EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these drug products.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

To report adverse events in animals, follow the instructions for submitting an electronic Form FDA 1932a at www.fda.gov/reportanimalAE.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.


These press releases may also interest you

at 00:18
OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for May 18, 2024. OKX...

at 00:10
Faraday Future Intelligent Electric Inc. ("Faraday Future," "FF," or the "Company"), a California-based global shared intelligent electric mobility ecosystem company, today announced that it is scheduled to have a conference call on its fourth...

17 mai 2024
xFusion Digital Technologies Co., Ltd. (xFusion) dazzled attendees with its top-of-the-range computing products and solutions at the prestigious ISC High Performance 2024 event, hosted at the Congress Center Hamburg in Germany from May 13th to 15th....

17 mai 2024
The highly anticipated HERImpact: Entrepreneurship for Impact Program launched yesterday in Chicago with a dynamic kickoff event at M Hub Chicago. This six-month virtual accelerator designed specifically for women entrepreneurs of color aims to...

17 mai 2024
In recent years, sedentary behaviour has become the norm for today's young people, and the problem of sedentary behavior is becoming more and more prevalent in the modern world. However, being sedentary may be detrimental to your health, triggering...

17 mai 2024
PAX Technology, Inc., a leading global payment solution provider, is excited to announce the release of its latest innovation, the Elys Display, a cutting-edge Kitchen Display System (KDS). Engineered for high-speed kitchen environments, this...



News published on and distributed by: